Kainos Laboratories Inc (4556)

Currency in JPY
1,262.0
+6.0(+0.48%)
Closed·

4556 Financial Summary

Key Ratios

P/E Ratio66.99
Price/Book2.07
Debt / Equity66.97%
Return on Equity3.11%
Dividend Yield2.77%
EBITDA298.49M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2006
31/03
2007
31/03
2008
31/03
2009
31/03
2010
31/03
* In Millions of JPY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 18.58%
Dividend Yield
2.77%
Industry Median 1.51%
Annualised payout
35.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 25, 2025
EPS / Forecast
43.57 / --
Revenue / Forecast
1.43B / --
EPS Revisions
Last 90 days

FAQ

What were Kainos Laboratories's earnings for the latest quarter?

The Kainos Laboratories EPS (TTM) is 18.58. Kainos Laboratories reported sales of 1,138.18, net income of 33.91, and EPS of 43.57 for the latest quarter.

What was Kainos Laboratories's net income for the latest quarter?

Kainos Laboratories's net income for the latest quarter was 33.91.

How did Kainos Laboratories's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1,073.10 in the previous quarter to 1,138.18 in the latest quarter, and net income moved from 33.10 to 33.91 compared to the previous quarter.

What is Kainos Laboratories's net profit margin on a TTM basis?

Kainos Laboratories's trailing twelve months (TTM) net profit margin is 2.41%.

How does Kainos Laboratories's debt to equity ratio compare to industry standards?

Kainos Laboratories's total debt-to-equity ratio is 66.97%.

What is Kainos Laboratories's return on investment on a TTM basis?

Kainos Laboratories's trailing twelve months (TTM) return on investment (ROI) is 3.11%.

Did Kainos Laboratories gain or lose cash last quarter?

In the latest quarter, Kainos Laboratories's net change in cash was 102.14 million.

What were Kainos Laboratories's total assets and liabilities in the latest quarter?

As of the latest quarter, Kainos Laboratories reported total assets of 5,724.01 million and total liabilities of 2,365.93 million.

How has Kainos Laboratories's total revenue grown this year?

Kainos Laboratories's total revenue was 1,073.10 in the previous quarter and 1,138.18 in the latest quarter.

What was Kainos Laboratories's revenue per share for the latest quarter?

Kainos Laboratories's revenue per share for the latest quarter was 1,669.55.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.